Published in Int J Hypertens on February 14, 2012
Exercise training in hypertension: Role of microRNAs. World J Cardiol (2014) 0.87
Effect of aminoguanidine on cardiovascular responses and survival time during blood loss: A study in normotensive and deoxycorticosterone acetate-salt hypertensive rats. Int J Appl Basic Med Res (2015) 0.77
Global burden of hypertension: analysis of worldwide data. Lancet (2005) 32.76
Endothelial dysfunction. J Am Soc Nephrol (2004) 3.18
Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension (2001) 3.04
A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation (2002) 2.76
Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation (2003) 2.69
Structure and function of small arteries. Physiol Rev (1990) 2.31
Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res (2002) 2.27
Microcirculation in hypertension: a new target for treatment? Circulation (2001) 2.21
Endothelial dysfunction as a target for prevention of cardiovascular disease. Diabetes Care (2009) 1.91
Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation (1998) 1.86
Spironolactone improves angiotensin-induced vascular changes and oxidative stress. Hypertension (2002) 1.81
Poiseuille and his law. Anaesthesia (1976) 1.81
Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants. Hypertension (2000) 1.63
Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats : effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation (1999) 1.31
Endothelial dysfunction: the common consequence in diabetes and hypertension. J Cardiovasc Pharmacol (2010) 1.27
Endothelial function and hypertension. Curr Opin Cardiol (2007) 1.22
Role of nitric oxide in central sympathetic outflow. Exp Biol Med (Maywood) (2001) 1.20
Nitric oxide and superoxide interactions in the kidney and their implication in the development of salt-sensitive hypertension. Clin Exp Pharmacol Physiol (2007) 1.15
Oxidative stress mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension (2005) 1.15
NAD(P)H oxidase inhibition improves endothelial function in rat and human blood vessels. Hypertension (2002) 1.15
Peripheral arterial stiffness and endothelial dysfunction in idiopathic and scleroderma associated pulmonary arterial hypertension. J Rheumatol (2009) 1.14
The macrocirculation and microcirculation of hypertension. Curr Hypertens Rep (2009) 1.07
Disturbance of macro- and microcirculation: relations with pulse pressure and cardiac organ damage. Am J Physiol Heart Circ Physiol (2007) 1.03
State-of-the-Art lecture. Role of endothelin-1 in hypertension. Hypertension (1999) 1.02
Effect of hyperhomocystinemia and hypertension on endothelial function in methylenetetrahydrofolate reductase-deficient mice. Arterioscler Thromb Vasc Biol (2003) 0.98
Endothelial function and common carotid artery wall thickening in patients with essential hypertension. Hypertension (1998) 0.96
Salt-sensitive hypertension in conscious rats induced by chronic nitric oxide blockade. Am J Hypertens (2002) 0.91
Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor. Hypertens Res (2008) 0.87
Endothelial dysfunction in essential hypertension: clinical implications. J Hypertens (2002) 0.86
Measurement of flow-mediated dilatation of the brachial artery is affected by local elastic vessel wall properties in high-risk patients. Atherosclerosis (2005) 0.85
Small artery mechanics in hyperhomocysteinemic mice: effects of angiotensin II. J Hypertens (2004) 0.85
Resistance artery mechanics and composition in angiotensin II-infused rats: effects of aldosterone antagonism. J Hypertens (2003) 0.84
Endothelial function assessment in complicated hypertension. Curr Pharm Des (2008) 0.84
Nitric oxide inhibition accelerates hypertension and induces perivascular inflammation in rats. Clin Exp Pharmacol Physiol (2004) 0.83
The heart, macrocirculation and microcirculation in hypertension: a unifying hypothesis. J Hypertens Suppl (2003) 0.82
Vascular function and nitric oxide production in chronic social-stress-exposed rats with various family history of hypertension. J Physiol Pharmacol (2007) 0.82
The participation of brain NO synthase in blood pressure control of adult spontaneously hypertensive rats. Mol Cell Biochem (2006) 0.81
The effect of chronic nitric oxide synthases inhibition on regulatory proteins in rat hearts. Mol Cell Biochem (2008) 0.80
Relation between brachial artery reactivity and noninvasive large and small arterial compliance in healthy volunteers. Am J Cardiol (2002) 0.79
Functional and structural pattern of arterial responses in hereditary hypertriglyceridemic and spontaneously hypertensive rats in early stage of experimental hypertension. Physiol Res (2006) 0.79
Arterial stiffness, endothelial function and microcirculatory reactivity in healthy young males. Clin Physiol Funct Imaging (2008) 0.78
Functional and morphological pattern of vascular responses in two models of experimental hypertension. Exp Clin Cardiol (2001) 0.78
Endothelium-derived relaxing and contracting factors. Adv Nephrol Necker Hosp (1990) 0.76
Clinical diagnosis in men undergoing infertility investigation in a university hospital. Urol Int (2006) 0.94
Beneficial effects of physical exercise on hypertension and cardiovascular adverse remodeling of diet-induced obese rats. Nutr Metab Cardiovasc Dis (2006) 0.82
Characterisation of hypertensive patients with improved endothelial function after dark chocolate consumption. Int J Hypertens (2013) 0.78
Altered vascular structure and wave reflection in hypertensive women with low magnesium levels. J Am Soc Hypertens (2013) 0.76
Oral magnesium supplementation improves endothelial function and attenuates subclinical atherosclerosis in thiazide-treated hypertensive women. J Hypertens (2017) 0.76